Clinical trial analytics

Clinical trial analytics covers the data analysis work that runs through a clinical trial's full lifecycle: designing the study and calculating required sample size, selecting and monitoring trial sites, tracking patient recruitment and retention, cleaning and monitoring incoming data for quality issues, and finally analyzing the primary and secondary endpoints once the trial concludes.

Most interventional trials are structured as a randomized controlled trial, where analytics is used to confirm randomization balance between arms, monitor for early safety signals that might require stopping the trial, and apply statistical tests to determine whether an observed treatment effect is likely real rather than chance. This differs from the analysis of real-world evidence, which works with observational data collected outside a controlled study design and needs different techniques to address confounding that randomization would otherwise handle automatically.

Clinical trial analytics matters because trials are expensive, slow, and the primary evidence regulators require before approving new treatments, so operational analytics that improve recruitment speed or site performance directly affect how quickly a treatment can reach patients. Output from completed trials also feeds health economics and outcomes research value assessments. A common pitfall is underpowering a trial — enrolling too few patients to reliably detect a real effect of the size the treatment is actually likely to have, which risks a false negative result.